Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mollnau

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Circulation Research|November 25, 2000
Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunctionM Oelze, H Mollnau, N Hoffmann, et al.
Circulation Research|January 11, 2000
Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailabilityT Münzel, H Li, H Mollnau, et al.
Circulation|May 23, 2001
Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aortaA Mülsch, M Oelze, S Klöss, et al.
Circulation Research|February 7, 2001
Mechanisms underlying endothelial dysfunction in diabetes mellitusU Hink, H Li, H Mollnau, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Circulation Research|November 25, 2000
Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunctionM Oelze, H Mollnau, N Hoffmann, et al.
Circulation Research|January 11, 2000
Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailabilityT Münzel, H Li, H Mollnau, et al.
Circulation|May 23, 2001
Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aortaA Mülsch, M Oelze, S Klöss, et al.
Circulation Research|February 7, 2001
Mechanisms underlying endothelial dysfunction in diabetes mellitusU Hink, H Li, H Mollnau, et al.
Pageof 2